2014 - Transplant Infectious Disease Conference


Multidrug resistant bacteria in solid organ transplant recipients

3.3 - Guidelines Overview: MDR Bacteria

Presenter: Carlos, Cervera, Barcelona, Spain
Authors: Carlos Cervera


Bacteria are the leading cause of infections after solid organ transplantation. In the recent years, a progressive growth in the incidence of multi-drug resistant strains has been observed. While MRSA infection is declining in non-transplant and SOT patients worldwide, vancomycin-resistant enterococci, MDR/XDR Enterobacteriaceae and MDR/XDR non-fermenters are progressively growing as a cause of infection is SOT patients and represent a global threat. Some SOT patients develop recurrent infections, related to anatomical defects in many cases, which are difficult-to-treat and predispose to the acquisition of MDR pathogens. As the antibiotics active against MDR bacteria have several limitations for its use, which include less clinical experience, higher incidence of adverse effects, less knowledge of the pharmacokinetics of the drug and, in most cases, are only available for parenteral administration, it is mandatory to know deeply the main characteristics of these drugs to safely treat SOT patients with MDR bacterial infections. Nonetheless, preventive measures are the cornerstone to control the spread of these pathogens. Thus, applying the CDC’s and ESCMID’s recommended antibiotic policies and strategies to control the transmission of MDR strains in the hospital is essential for the management of SOT patients.

In this lecture, a description of the recommendations proposed by the ESCMID Study Group for Infections in Compromised Hosts for the prevention and management of MDR bacteria infections in solid organ transplantation will be discussed.


You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi